Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
In this study we have determined the incidence of hepatocellular carcinoma (HCC) development in primary biliary cirrhosis (PBC) and its effects on patient survival. Six hundred and sixty seven patients with liver histology compatible with or diagnostic of PBC were seen over a 20-year period. Two hundred and seventy three patients who had stage III or IV disease on their last biopsy and who had been followed up for at least 1 year following that biopsy (total follow-up with advanced disease 2,010 patient years) were identified (243 female, 30 male). Patients who developed HCC were identified and their confounding risk factors were excluded. Mayo risk scores were calculated for each clinic attendance and expected survival for each time point was compared with subsequent actual survival. Sixteen cases of HCC were seen in the patients with stage III or IV disease on last biopsy, providing an overall incidence of 5.9% in this group. Fourteen of these patients had died of HCC related causes, and 2 patients were alive at the census point. The incidence of HCC was significantly higher in males with stage III/IV disease than in females (20% vs. 4.1%, P < .005). Nine of one hundred and eight (8.3%) total female deaths in this group was attributable to HCC compared with 5 of 11 (45.5%, P < .05) male deaths. HCC was not seen in any of the 394 patients with stage I and II PBC followed-up over the same time period. Throughout the disease course of all PBC patients with HCC, the Mayo prognostic model over-predicted survival. Whereas it is a relatively rare complication of cirrhotic PBC in women, HCC is a relatively common cause of death in male PBC patients with cirrhosis. HCC typically develops several years after the onset of cirrhosis, and is poorly predicted by prognostic models. In view of these findings, consideration should be given to careful screening for HCC in male PBC patients with cirrhosis. The risk of HCC development may be an additional reason to consider earlier transplantation in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The incidence of HCC among patients with diagnosed PBC is estimated at 0.36 per 100 person years.Higher histological stage on liver biopsy denotes an increased risk for HCC in patients with PBC [249].A recent multicentre study from North America and Europe, based on prolonged observation of 4,565 patients with PBC, showed an incidence rate of 3.4 HCC cases for every 1,000 patient-years [8].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [249]
In the citing paper
“Surveillance with regular imaging was associated with better clinical outcome of PBC patients who develop HCC.(227)(228)(229)(230)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [227]
Citations
Cites
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Ikeda, K. (1993) · Hepatology · doi:10.1016/0270-9139(93)90505-h · Cited by 620
Symposium: Advances in Liver Pathology [Abridged]: Primary Biliary Cirrhosis
Scheuer, P. J. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706001205 · Cited by 557
Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487
Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 455
DI BISCEGLIE, A. M., RUSTGI, V. K., HOOFNAGLE, J. H., DUSHEIKO, G. M., & LOTZE, M. T. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-390 · Cited by 454
Nomura, F., Ohnishi, K., & Tanabe, Y. (1989) · Cancer · doi:10.1002/1097-0142(19891015)64:8<1700::aid-cncr2820640824>3.0.co;2-z · Cited by 305
Relationship Between Hepatocellular Carcinoma and Cirrhosis
Kew, M., & Popper, H. (1984) · Seminars in Liver Disease · doi:10.1055/s-2008-1040653 · Cited by 260
ZAMAN, S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91785-4 · Cited by 257
Efficacy of Liver Transplantation in Patients with Primary Biliary Cirrhosis
Markus, B. H., Dickson, E. R., Grambsch, P. M., Fleming, T. R., Mazzaferro, V., Klintmalm, G. B. G., Wiesner, R. H., Van Thiel, D. H., & Starzl, T. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202602 · Cited by 234
Connett, J. E., Kuller, L. H., Kjelsberg, M. O., Polk, B. F., Collins, G., Rider, A. A., & Hulley, S. B. (1989) · Cancer · doi:10.1002/1097-0142(19890701)64:1<104::aid-cncr2820640119>3.0.co;2-5 · Cited by 145
Wiesner, R. H., Porayko, M. K., Dickson, R. E., Gores, G. J., LaRusso, N. F., Hay, E. J., Wahlstrom, E. H., & Krom, R. A. F. (1992) · Hepatology · doi:10.1002/hep.1840160527 · Cited by 142
De Bac, C., Stroffolini, T., Gaeta, G. B., Taliani, G., & Giusti, G. (1994) · Hepatology · doi:10.1002/hep.1840200519 · Cited by 134
The Geoepidemiology of Primary Biliary Cirrhosis
Metcalf, J., & James, O. (1997) · Seminars in Liver Disease · doi:10.1055/s-2007-1007179 · Cited by 101
Self-citationCancer Risk in Primary Biliary Cirrhosis: A Population–Based Study From Sweden
Lööf, L., Adami, H.-O., Sparén, P., Danielsson, Å., Eriksson, L. S., Hultcrantz, R., Lindgren, S., Olsson, R., Prytz, H., Ryden, B.-O., et al. (1994) · Hepatology · doi:10.1002/hep.1840200116 · Cited by 83
Hepatocellular carcinoma in primary biliary cirrhosis: Detection by α-fetoprotein estimation
Melia, W. M., Johnson, P. J., Neuberger, J., Zaman, S. N., Portmann, B. G., & Williams, R. L. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90540-7 · Cited by 83
Curley, S. A., Izzo, F., Gallipoli, A. D., Bellis, M. D., Cremona, F., & Parisi, V. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00014 · Cited by 67
Hepatocellular carcinoma in primary biliary cirrhosis
Farinati, F., Floreani, A., DEMARIA, N., FAGIUOLI, S., Naccarato, R., & Chiaramonte, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80307-1 · Cited by 61
Kaczynski, J., Hansson, G. K., & Wallerstedt, S. M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.24 · Cited by 47
Prediction of survival of patients with primary biliary cirrhosis
Klion, F. M., Fabry, T. L., Palmer, M., & Schaffner, F. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91815-l · Cited by 46
Clinical Features and Prognosis of Hepatocellular Carcinoma in Britain in Relation to Age
Collier, J. D., Curless, R. H., Bassendine, M. F., & James, O. (1994) · Age and Ageing · doi:10.1093/ageing/23.1.22 · Cited by 42
Self-citationSaracco, S., Abramowsky, C. R., Taylor, S., Silverman, R. A., & Berman, B. (1988) · Cancer · doi:10.1002/1097-0142(19880801)62:3<611::aid-cncr2820620328>3.0.co;2-0 · Cited by 37
PROGNOSIS AFTER LIVER TRANSPLANTATION FOR PRIMARY BILIARY CIRRHOSIS
Neuberger, J., Altman, D. G., Polson, R. J., Buckels, J. A. C., Rolles, K., Elias, E., Calne, R., McMaster, P., & Williams, R. L. (1989) · Transplantation · doi:10.1097/00007890-198909000-00019 · Cited by 36
1 Aetiological factors in hepatocellular cancer
Bassendine, M. F. (1987) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(87)90031-5 · Cited by 31
Self-citationHepatocellular carcinoma in primary biliary cirrhosis.
Turissini, S. B., & Kaplan, M. M. (1997) · PubMed · Cited by 28
Cancer risk in primary biliary cirrhosis: A population-based study from Sweden
Loof, L. (1994) · Hepatology · doi:10.1016/0270-9139(94)90140-6 · Cited by 17
Ursodeoxycholic acid therapy in primary biliary cirrhosis
Jones, D. E. J., James, O., & Bassendine, M. F. (1995) · Hepatology · doi:10.1002/hep.1840210535 · Cited by 15
Self-citationChromosome abnormalities in familial hemophagocytic lymphohistiocytosis
Kletzel, M., Gollin, S. M., Gloster, E. S., Jimenez, J. F., Golladay, E. S., & Berry, D. H. (1986) · Cancer · doi:10.1002/1097-0142(19860601)57:11<2230::aid-cncr2820571126>3.0.co;2-5 · Cited by 11
Enhancement of aflatoxin B1-induced hepatocarcinogenesis in rats by partial hepatectomy
Rizvi, T. A., Mathur, M., & Nayak, N. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890036 · Cited by 10
Selection and Timing of Liver Transplantation
Freeman, R. B. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch42 · Cited by 2
Cited by
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“with impaired prognosis [243,244].”
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citation(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Metadata
- Authors
- Jones, D. E., Metcalf, J. V., Collier, J. D., Bassendine, M. F., & James, O. F.
- Affiliations
- Newcastle University (GB)
- Venue
- Hepatology
- Published
- 1997-11
- Volume
- 26
- Issue
- 5
- Pages
- 1138-1142
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2072040942
- Semantic Scholar
- f9368989eb2050966bd77bdcbaf009cd6c7ef523
- Cited by
- 161
- References
- 32
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 2 · 2018: 5 · 2017: 8 · 2016: 5 · 2015: 7 · 2014: 4 · 2013: 8 · 2012: 5
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6513 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- hepatocellular carcinoma, primary biliary cirrhosis, HCC incidence, survival, Mayo risk score, sex differences, advanced liver disease, HCC screening, liver transplantation
- MeSH terms
- Aged, Aged, 80 and over, alpha-Fetoproteins, Female, Follow-Up Studies, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Biliary, Liver Neoplasms, Longitudinal Studies, Male, Middle Aged, Prognosis, Risk Factors, Cohort Studies, Incidence, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.